The diagnosis of prion diseases

Parasitology

Volumn 117, Issue 7, 1999, Pages 3-11

  Knight, R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

14 3 3; CJD; CSF; EEG; Prion

Indexed keywords

CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC TEST; ECONOMIC ASPECT; ELECTROENCEPHALOGRAM; HUMAN; IMAGING; NONHUMAN; POLITICS; PRION DISEASE; PRIORITY JOURNAL; REVIEW;

CREUTZFELDT-JAKOB SYNDROME; HUMANS; PRION DISEASES; PRIONS;

ANIMALIA;

EID: 0032300116     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182099004138     Document Type: Article

References (21)

1. Amouyel, F., Vidal, O., Launay, S. M. & Laplanche, J. L. (1994). The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 344, 1315–1318.
2. Cervenakova, L., Brown, P., Piccardo, P., Cummings, J. L., Nagle, J., Vinters, H. V., Kaur, P., Ghetti, B., Chapman, J., Gadjusek D. C. & Goldfarb, L. G. (1996). 24-nucleotide deletion in the PRNP gene: analysis of associated phenotypes. In Transmissible Subacute Spongiform encephalopathies. Prion Disease. (ed. Court, L. & Dodet, B.), pp. 433–444. Paris, Elsevier.
3. Collee J. G. & Bradley R. (1997). BSE: a decade on part 1. Lancet 349, 636–641.
4. Collee J. G.& Bradley R. (1997). BSE: a decade on part 2. Lancet 349, 715–721.
5. Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J. & Hill A. F. (1999). Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383, 685–690.
6. De Silva, W., Patterson, J., Hadley, P., Russell, A., Turner M. & Zeidler M. (1998). Single photon emission computed tomography in the identification of new variant Creutzfeldt-Jakob disease: case reports. British Medical Journal 316, 593–594.
7. Finkenstaedt, M., Szudra, A., Zerr, I., Poser, S., Heise, J. H. Stoebner J. M. & Weber T. (1996). MR imaging of Creutzfeldt-Jakob Disease. Radiology 199, 793–798.
8. Harrington, M. G., Merril, C. R., Asher, D. M. & Gajdusek D. C. (1986). Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. New England Journal of Medicine 315, 279–283.
9. Hill, A. F., Zeidler, M., Ironside, J. & Collinge, J. (1997). Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349, 99-100.
10. Hochstrasser, D. F., Frutiger, S., Wilkins, M. R., Hughes G. Sanchez J.-C. (1997). Elevation of apolipoprotein E in the CSF of cattle affected by BSE. FEBS Letters 416, 161–163.
11. Hsich, G., Kenny, K., Gibbs, C. J. Jr., Lee, K. H. & Harrington M. G. (1996). The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. New England Journal of Medicine 335, 924–930.
12. Korth, C., Stierli, B., Streit, P., Moser, M., Schaller, O., Fischer, R., Schulz-Schaeffer, W., Kretzschmar, H., Raeber, A., Brawn, U., Ehrensperger, F., Hornemann, S., Glockshuber, R., Riek, R., Billeter, M. Wurthrich K. & Oesch B. (1997). Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390, 74–77.
13. Lee K. H. & Harrington M. G. (1996). Premortem diagnosis of Creutzfeldt-Jakob disease by cerebrospinal fluid analysis. Lancet 348, 887.
14. Nakagawa, Y., Kitamoto, T., Furukawa, H., Ogomori, K. & Tateishi J. (1995). Apolipoprotein E in
15. Otto, M., Stein, H., Szudra, A., Zerr, I., Bodemar, M., Gefeller, O., Poser, S., Kretzschmar, H. A., Mader, M. & Weber T. (1997). S100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Journal of Neurology 244, 510–556.
16. Otto, M., Wiltfang, J., Schutz, E., Zerr, I., Otto, A., Pfahlberg, A., Gefellar, O., Uhr, M., Giese, A., Weber, T. Kretzschmar H. A.& Poser S. (1998). Diagnosis of Creutzfeldt-Jakob disease by measurement of 5100 protein in serum: prospective case-control study. British Medical Journal 316, 577–582.
17. Steinhoff, B. J., Racker, S., Herrendoff, G., Poser, S., Grosche, S., Zerr, I., Kretzschmar, H. A. & Weber, T. (1996). Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Archives of Neurology 53, 162–166.
18. Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Esterbeiro, K., Aperovitch, A., Poser, S., Pocchiari, M. Hoffman A. & Smith P. G. (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921–925.
19. Zeidler, M., Will, R. G., Ironside, J., Sellar, R. & Wardlaw J. (1996). Magnetic resonance imaging is not a sensitive test for Creutzfeldt-Jakob disease. British Medical Journal 312, 844.
20. Zerr, I., Bodemer, M., Otto, M., Poser, S., Windal, O., Kretzschmar, H. A., Gefeller, O. & Weber, T. (1996). Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 348, 846–849.
21. Zerr, J., Bodemer, M., Racker, S., Grosche, S., Poser, S., Kretzschmar, H. A. & Weber, T. (1995). Cerebrospinal fluid concentration of neuron specific enolase in diagnosis of Creutzfeldt—Jakob disease. Lancet 345, 1609–1610.